Geoffrey M. Parker's Insider Trades & SAST Disclosures
Geoffrey M. Parker's most recent trade in Perrigo Company plc was a trade of 9,904 Ordinary Shares done at an average price of $26.0 . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Geoffrey M. Parker.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.01 per share. | 14 May 2025 | 9,904 | 33,666 (0%) | 0% | 26.0 | 257,603 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 9,904 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 7,305 | 7,305 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.01 per share. | 14 May 2025 | 4,754 | 28,912 (0%) | 0% | 26.0 | 123,652 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 27.10 per share. | 12 May 2025 | 3,500 | 23,762 (0%) | 0% | 27.1 | 94,850 | Ordinary Shares |
| Allogene Therapeutics Inc | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.73 per share. | 03 Feb 2025 | 4,361 | 1,301,540 (1%) | 0% | 1.7 | 7,545 | Common Stock |
| Allogene Therapeutics Inc | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 614,844 | 614,844 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 173,913 | 1,305,901 (1%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. | 21 Oct 2024 | 36,404 | 1,131,988 (0%) | 0% | 2.8 | 103,387 | Common Stock |
| Allogene Therapeutics Inc | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 2.90 per share. | 16 May 2024 | 344,828 | 1,164,418 (0%) | 0% | 2.9 | 1,000,001 | Common Stock |
| Perrigo Company plc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 9,904 | 9,904 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.22 per share. | 14 May 2024 | 8,764 | 24,469 (0%) | 0% | 30.2 | 264,848 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 8,764 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.22 per share. | 14 May 2024 | 4,207 | 20,262 (0%) | 0% | 30.2 | 127,136 | Ordinary Shares |
| Allogene Therapeutics Inc | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 3.59 per share. | 30 Jan 2024 | 190 | 819,590 (0%) | 0% | 3.6 | 683 | Common Stock |
| Allogene Therapeutics Inc | M. Geoffrey Parker | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 103,939 | 103,939 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Parker M. Geoffrey | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 29,400 | 819,400 (0%) | 0% | 0 | Common Stock | |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 3,750 | 1,031,805 | - | 0 | Common Stock | |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 27 Jul 2023 | 685,025 | 1,028,055 | - | 0.7 | 500,000 | Common Stock |
| Perrigo Company plc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 33.06 per share. | 13 Jun 2023 | 10,000 | 25,879 (0%) | 0% | 33.1 | 330,637 | Ordinary Shares |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 7,778 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.86 per share. | 17 May 2023 | 7,778 | 19,439 (0%) | 0% | 32.9 | 255,585 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.86 per share. | 17 May 2023 | 3,734 | 15,705 (0%) | 0% | 32.9 | 122,699 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 8,764 | 8,764 | - | - | Restricted Stock Units | |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 10 Apr 2023 | 303,030 | 343,030 | - | 0.8 | 250,000 | Common Stock |
| Perrigo Company plc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 38.05 per share. | 06 Mar 2023 | 5,000 | 15,879 (0%) | 0% | 38.1 | 190,270 | Ordinary Shares |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 13 Jun 2022 | 25,000 | 40,000 | - | 1.4 | 36,183 | Common Stock |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 7,778 | 7,778 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.57 per share. | 17 May 2022 | 6,599 | 14,829 (0%) | 0% | 38.6 | 254,523 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 6,599 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.57 per share. | 17 May 2022 | 3,168 | 11,661 (0%) | 0% | 38.6 | 122,190 | Ordinary Shares |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 2.15 per share. | 29 Mar 2022 | 15,000 | 15,000 | - | 2.1 | 32,231 | Common Stock |
| Perrigo Company plc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 36.85 per share. | 16 Dec 2021 | 5,000 | 10,879 (0%) | 0% | 36.9 | 184,270 | Ordinary Shares |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 4.94 per share. | 14 Dec 2021 | 20,000 | 53,333 | - | 4.9 | 98,800 | Common Stock |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 33,333 | 33,333 | - | - | Common Stock | |
| Better Therapeutics Inc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 28,300 | 28,300 | - | - | Stock Option (Right to Buy) | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 6,599 | 6,599 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 5,804 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Geoffrey M. Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.96 per share. | 07 May 2021 | 5,804 | 14,245 (0%) | 0% | 43.0 | 249,340 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.96 per share. | 07 May 2021 | 2,786 | 11,459 (0%) | 0% | 43.0 | 119,687 | Ordinary Shares |
| Perrigo Company plc | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 41.29 per share. | 17 Mar 2021 | 2,500 | 2,650 (0%) | 0% | 41.3 | 103,218 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges